Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 23, Issue 4, Pages 323-334
Publisher
Bioscientifica
Online
2016-05-19
DOI
10.1530/erc-16-0068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Targetable Androgen Receptor–Positive Breast Cancer Subtype Hidden Among the Triple-Negative Cancers
- (2015) Damoun Safarpour et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
- (2015) F Caiazza et al. BRITISH JOURNAL OF CANCER
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development
- (2015) T. Proverbs-Singh et al. ENDOCRINE-RELATED CANCER
- 1802 Overall survival (OS) from the phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) signaling inhibitor, in AR+ advanced triple-negative breast cancer (aTNBC)
- (2015) J. Cortes et al. EUROPEAN JOURNAL OF CANCER
- Sp1 and the ‘hallmarks of cancer’
- (2015) Kate Beishline et al. FEBS Journal
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Androgen receptors beyond prostate cancer: an old marker as a new target
- (2015) Javier Munoz et al. Oncotarget
- New Strategies for Triple-Negative Breast Cancer--Deciphering the Heterogeneity
- (2014) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- Enzalutamide: looking back at its preclinical discovery
- (2014) Yun-Sok Ha et al. Expert Opinion on Drug Discovery
- Taxonomy of breast cancer based on normal cell phenotype predicts outcome
- (2014) Sandro Santagata et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
- (2014) Pierluigi Gasparini et al. PLoS One
- Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
- (2013) Keely M. McNamara et al. CANCER SCIENCE
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- The Impact of Androgen Receptor Expression on Breast Cancer Survival: A Retrospective Study and Meta-Analysis
- (2013) Qing Qu et al. PLoS One
- Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells
- (2013) Gabriella Castoria et al. PLoS One
- Targeted therapy for triple-negative breast cancer: Where are we?
- (2012) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
- (2012) T. E. Hickey et al. MOLECULAR ENDOCRINOLOGY
- Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
- (2012) Christine Vogel et al. NATURE REVIEWS GENETICS
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
- (2011) R. Hu et al. CLINICAL CANCER RESEARCH
- Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: Comparison with manual counting
- (2011) Zhongli Cai et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2011) Laura C Collins et al. MODERN PATHOLOGY
- Androgens and breast cancer
- (2011) Joanne Kotsopoulos et al. STEROIDS
- Triple-Negative Breast Cancer
- (2010) Ayca Gucalp et al. CANCER JOURNAL
- Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with hormone responsive advanced breast cancer: no evidence of a pharmacokinetic interaction between exemestane and fulvestrant.
- (2010) E Mrozek et al. CANCER RESEARCH
- Expression of androgen receptors in primary breast cancer
- (2009) S. Park et al. ANNALS OF ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Translational regulation mechanisms of AP-1 proteins
- (2009) Paul Willi Vesely et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
- (2009) Jessica Kao et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation